Nordhealth AS Statistics

Total Valuation

Nordhealth AS has a market cap or net worth of NOK 2.98 billion. The enterprise value is 2.75 billion.

Market Cap	2.98B
Enterprise Value	2.75B

Important Dates

The last earnings date was Tuesday, March 4, 2025.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Nordhealth AS has 79.07 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	79.07M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	49.24%
Owned by Institutions (%)	18.65%
Float	38.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	81.28
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	13.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 75.71, with an EV/FCF ratio of -73.71.

EV / Earnings	-30.47
EV / Sales	5.12
EV / EBITDA	75.71
EV / EBIT	n/a
EV / FCF	-73.71

Financial Position

The company has a current ratio of 2.99

Current Ratio	2.99
Quick Ratio	2.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-208.81

Financial Efficiency

Return on equity (ROE) is -9.81% and return on invested capital (ROIC) is -6.17%.

Return on Equity (ROE)	-9.81%
Return on Assets (ROA)	-5.52%
Return on Invested Capital (ROIC)	-6.17%
Return on Capital Employed (ROCE)	-10.46%
Revenue Per Employee	1.31M
Profits Per Employee	-219,613
Employee Count	411
Asset Turnover	0.52
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.04% in the last 52 weeks. The beta is 0.45, so Nordhealth AS's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+46.04%
50-Day Moving Average	39.80
200-Day Moving Average	36.73
Relative Strength Index (RSI)	44.04
Average Volume (20 Days)	14,240

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nordhealth AS had revenue of NOK 537.23 million and -90.26 million in losses.

Revenue	537.23M
Gross Profit	184.25M
Operating Income	-90.87M
Pretax Income	-78.08M
Net Income	-90.26M
EBITDA	36.32M
EBIT	-90.87M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 230.79 million in cash and n/a in debt, giving a net cash position of 230.79 million or 2.92 per share.

Cash & Cash Equivalents	230.79M
Total Debt	n/a
Net Cash	230.79M
Net Cash Per Share	2.92
Equity (Book Value)	866.06M
Book Value Per Share	n/a
Working Capital	213.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.74 million and capital expenditures -59.04 million, giving a free cash flow of -37.31 million.

Operating Cash Flow	21.74M
Capital Expenditures	-59.04M
Free Cash Flow	-37.31M
FCF Per Share	-0.47

Full Cash Flow Statement

Margins

Gross margin is 34.30%, with operating and profit margins of -16.92% and -16.80%.

Gross Margin	34.30%
Operating Margin	-16.92%
Pretax Margin	-14.53%
Profit Margin	-16.80%
EBITDA Margin	6.76%
EBIT Margin	-16.92%
FCF Margin	n/a

Dividends & Yields

Nordhealth AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.03%
FCF Yield	-1.25%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a